
BiVACORrevenue
Houston, TexasFounded 2008CEO Jim Dillon
BiVACOR® is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure, including the development of the world's first titanium Total Artificial Heart (TAH).
BiVACOR revenue
BiVACOR has not published its revenue. Growjo puts it at about $18.6M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $18.6MEST | Growjo estimate |
BiVACOR CEO & employees
Jim Dillon is CEO of BiVACOR. BiVACOR has 57 employees (September 2025, LinkedIn).
- Jim DillonCEO
BiVACOR FAQ
What is BiVACOR's revenue?
Growjo estimates BiVACOR's revenue at about $18.6M a year (September 2025). The company hasn't published its own figure.
How many employees does BiVACOR have?
BiVACOR has 57 employees as of September 2025, according to LinkedIn.
Who is the CEO of BiVACOR?
Jim Dillon is the CEO of BiVACOR.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun BiVACOR? Join the podcast